Update of the EORTC Questionnaire for Assessing the Quality of Life in Lung Cancer Patients (EORTC QLQ-LC13) Phases I - III
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Cancer
Both
Lung Cancer
Trial Information
Update of the EORTC Questionnaire for Assessing the Quality of Life in Lung Cancer Patients (EORTC QLQ-LC13) Phases I - III
Inclusion Criteria:
- confirmed diagnosis of lung cancer
- informed consent
- capability to respond to a questionnaire and to follow an interview
Exclusion Criteria:
- no informed consent
- lack of capability to respond to a questionnaire
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Importance of quality of life issues from patients' perspective
Outcome Description:
Importance of quality of life issues are assessed using a four-point scale (1= not at all, 2 = a little, 3 = quite a bit, 4 = very much. Only issues with a mean of > 2 are considered for inclusion in the questionnaire.
Outcome Time Frame:
in the course or up to three months after having completed therapy
Safety Issue:
No
Authority:
Germany: Ethics Commission
Study ID:
Koller Lung 03/2010
NCT ID:
NCT01434784
Start Date:
September 2011
Completion Date:
January 2013
Related Keywords:
- Lung Cancer
- lung cancer
- quality of life
- Lung Neoplasms
Name | Location |
|---|
